IceCure Medical
ICCM
12 hedge funds and large institutions have $127K invested in IceCure Medical in 2023 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 5 closing their positions.
50% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 2
0.01% more ownership
Funds ownership: 0.01% → 0.02% (+0.01%)
0% more funds holding
Funds holding: 12 → 12 (0)
0% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 5
30% less capital invested
Capital invested by funds: $181K → $127K (-$54K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$76.1K |
| 2 |
VF
Virtu Financial
New York
|
+$25K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$16.3K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$15.5K |
| 5 |
TSS
Two Sigma Securities
New York
|
+$10.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BFM
Boothbay Fund Management
New York
|
-$46.4K |
| 2 |
Renaissance Technologies
New York
|
-$22K |
| 3 |
Osaic Holdings
Scottsdale,
Arizona
|
-$6.58K |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$5.19K |
| 5 |
SIGI
Susquehanna International Group (Ireland)
Dublin,
Ireland
|
-$1.1K |
ICCM Hedge Fund Activity: Q3 2023 in Review
12 of the 6,302 institutional investors tracked by Wall St. Rank reported a position in IceCure Medical (ICCM) for Q3 2023, worth a combined $127K — down 30% from $181K a quarter earlier.
Fund positioning in ICCM was balanced in Q3 2023: 5 funds opened new positions, 5 closed out, 3 added to existing stakes and 2 trimmed.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $76.1K. The largest seller was Boothbay Fund Management, exiting entirely with an estimated $46.4K sold.
- 12 institutional investors held IceCure Medical (ICCM) as of Q3 2023, unchanged from Q2 2023.
- Funds reported $127K of IceCure Medical stock for Q3 2023, down 30% quarter-over-quarter.
- 5 funds opened new IceCure Medical positions in Q3 2023 and 5 closed out, a net change of 0 holders.
- The largest IceCure Medical buyer in Q3 2023 was Citadel Advisors, an estimated $76.1K added.
- The largest IceCure Medical seller in Q3 2023 was Boothbay Fund Management, an estimated $46.4K sold.
Based on aggregated 13F filings for Q3 2023.